Tazarotene

NDC 73473-309 · Solaris Pharma Corporation

Generic nameTazarotene

Dosage formGEL

RouteCUTANEOUS

Active ingredient(s)TAZAROTENE

Strength.5 mg/g

Pharmacologic classRetinoid [EPC], Retinoids [CS]

Marketing categoryANDA

Packages

73473-309-10 — 1 TUBE in 1 CARTON (73473-309-10) / 100 g in 1 TUBE

73473-309-30 — 1 TUBE in 1 CARTON (73473-309-30) / 30 g in 1 TUBE

FDA lists these products with the same active ingredient.

0713-0670 — Tazarotene, 0713-0765 — Tazarotene, 0713-0804 — tazarotene, 0713-0805 — tazarotene, 16110-042 — tazarotene, 16110-833 — tazarotene, 16110-915 — tazarotene, 16110-916 — tazarotene, 45802-436 — tazarotene, 45802-442 — tazarotene, 45802-706 — tazarotene, 51672-1373 — Tazarotene, 51672-1374 — Tazarotene, 51862-295 — tazarotene, 68308-685 — tazarotene, 68308-745 — TAZAROTENE, 72162-2202 — tazarotene, 72162-2420 — tazarotene, 73473-310 — Tazarotene, 87143-200 — TAZAROTENE, +2 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.